Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

Journal of Clinical Oncology

Volumn 17, Issue 10, 1999, Pages 3299-3306

  Loprinzi, Charles L ^a   Kugler, John W ^a   Sloan, Jeff A ^a   Mailliard, James A ^a   Krook, James E ^a   Wilwerding, Mary B ^a   Rowland Jr , Kendrith M ^a   Camoriano, John K ^a   Novotny, Paul J ^a   Christensen, Bradley J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUOXYMESTERONE; MEGESTROL ACETATE;

ADULT; AGED; ANOREXIA; APPETITE; ARTICLE; CACHEXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUSHINGOID SYNDROME; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MYOPATHY; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; VIRILIZATION;

EID: 0032887010     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.10.3299     Document Type: Article

References (28)

1. Moertel CG, Schutt AJ, Reitemeier RJ, et al: Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 33:1607-1609, 1974
2. Bruera E, Roca E, Cedaro L, et al: Action of oral methylprednisolone in terminal cancer patients : A prospective randomized double-blind study. Cancer Treat Rep 69:751-754, 1985
3. Popiela T, Lucchi R, Giongo F: Methylprednisolone as an appetite stimulant in patients with cancer. Eur J Cancer Clin Oncol 25:1823-1829, 1989
4. Wilcox J, Corr J, Shaw J, et al: Prednisolone as an appetite stimulant in patients with cancer. BMJ 288:27, 1984
5. Loprinzi CL, Ellison NM, Schaid DJ, et al: Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82:1127-1132, 1990
6. Bruera E, Macmillan K, Kuehn N, et al: A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279-1282, 1990
7. Feliu J, Gonzalez Baron M, Berrocal A, et al: Usefulness of megestrol acetate in cancer cachexia and anorexia: A placebo-controlled study. Am J Clin Oncol 15:436-440, 1992
8. Tchekmedyian NS, Hickman M, Siau J, et al: Megestrol acetate in cancer anorexia and weight loss. Cancer 69:1268-1274, 1992
9. Von Roenn JH, Armstrong D, Kotler DP, et al: Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 121:393-399, 1994
10. Loprinzi CL, Michalak JC, Schaid DJ, et al: Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 11:762-767, 1993
11. Loprinzi CL, Jensen MD, Jiang NS, et al: Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc 67:1160-1162, 1992
12. Leinung MC, Liporace R, Miller CH: Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med 122:843-845, 1995
13. Freed DJ, Banks AJ, Longson D, et al: Anabolic steroids in athletics: Crossover double-blind trial on weightlifters. BMJ 5:471-473, 1975
14. Chlebowski RT, Herrold J, Ali I, et al: Influence of nadrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 58:183-186, 1986
15. Kardinal CG, Loprinzi CL, Schaid DJ, et al: A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 65:2657-2661, 1990
16. Goldberg RM, Loprinzi CL, Mailliard JA, et al: Pentoxifylline for treatment of cancer anorexia/cachexia? A randomized, double-blinded, placebo-controlled trial. J Clin Oncol 13:2856-2859, 1995
17. Therneau TM: How many stratification factors are "too many" to use in a randomization plan? Control Clin Trials 14:98-108, 1993
18. Sloan JA, Loprinzi CL, Kuross SA, et al: A randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 16:3662-3673, 1998
19. Rowland KM, Loprinzi CL, Shaw EG, et al: Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol 14:135-141, 1996
20. O'Brien PC, Fleming TR: A multiple testing procedure for clinical trials. Biometrics 35:549-556, 1979
21. Sloan JA, Loprinzi CL, Laurie J, et al: A simple stratification factor prognostic for survival in advanced cancer: The GBU index. Proc Am Soc Clin Oncol 17:557a, 1998 (abstr 2136)
22. DeWys WD, Begg C, Lavin PT, et al: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491-497, 1980
23. Bruera E, MacDonald RN: Asthenia in patients with advanced cancer. J Pain Symptom Manage 3:9-14, 1988
24. Lai YL, Fan FM, Yeh CY: Management of anorexic patients in radiotherapy: A prospective randomized comparison of megestrol and prednisolone. J Pain Symptom Manage 9:265-268, 1994
25. 1998 Drug Topics Red Book. Montvale, NJ, Medical Economics Company, 1998
26. Gaver RC, Pittman KA, Reilly CM, et al: Bioequivalence evaluation of new megestrol acetate formulations in humans. Semin Oncol 12:17-19, 1985 (suppl 1)
27. Robertson CL, Marques CB, Gralla RJ, et al: Documenting the rapidity of pain relief and palliation of other lung cancer symptoms with the use of dexamethasone. Proc Am Soc Clin Oncol 16:80a, 1997 (abstr 280)
28. Bruera E, Ernst S, Hagen N, et al: Symptomatic effects of megestrol acetate (MA): A double-blind, crossover study. Proc Am Soc Clin Oncol 15:531, 1996 (abstr 1716)